Harvest Healthcare Leaders Income ETF (TSX:HHL)
Assets | 1.37B |
Expense Ratio | 1.06% |
PE Ratio | 20.87 |
Dividend (ttm) | 0.72 |
Dividend Yield | 10.29% |
Ex-Dividend Date | Jun 30, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 216.19% |
1-Year Return | -12.03% |
Volume | 555,573 |
Open | 7.01 |
Previous Close | 7.00 |
Day's Range | 6.95 - 7.02 |
52-Week Low | 6.94 |
52-Week High | 8.95 |
Beta | 1.15 |
Holdings | 24 |
Inception Date | Nov 19, 2014 |
About HHL
Harvest Healthcare Leaders Income ETF is an exchange traded fund launched and managed by Harvest Portfolios Group Inc. The fund invests in public equity markets of the United States and Canada region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the MSCI World Health Care Net Total Return Index. Harvest Healthcare Leaders Income ETF was formed on November 19, 2014 and is domiciled in Canada.
Performance
HHL had a total return of -12.03% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.98%.
Top 10 Holdings
51.48% of assetsName | Symbol | Weight |
---|---|---|
Agilent Technologies, Inc. | A | 5.32% |
Novartis AG ADR | NVSN.MX | 5.31% |
Boston Scientific Corporation | BSX | 5.26% |
Abbott Laboratories | ABT | 5.24% |
Medtronic plc | MDT | 5.18% |
Intuitive Surgical, Inc. | ISRG | 5.13% |
Stryker Corporation | SYK | 5.11% |
Zoetis Inc. | ZTS | 5.05% |
Danaher Corporation | DHR | 4.94% |
Johnson & Johnson | JNJ | 4.93% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 30, 2025 | 0.060 CAD | Jul 9, 2025 |
May 30, 2025 | 0.060 CAD | Jun 9, 2025 |
Apr 30, 2025 | 0.060 CAD | May 9, 2025 |
Mar 31, 2025 | 0.060 CAD | Apr 9, 2025 |
Feb 28, 2025 | 0.060 CAD | Mar 7, 2025 |
Jan 31, 2025 | 0.060 CAD | Feb 7, 2025 |